title: [Circulatory insufficiency during prevention of thrombosis with heparin/dihydroergotamine. Effect or side-effect?].
authors.forename: L C
authors.initials: LC
authors.lastname: Borris
authors.forename: M R
authors.initials: MR
authors.lastname: Lassen
authors.forename: H M
authors.initials: HM
authors.lastname: Christiansen
authors.forename: F
authors.initials: F
authors.lastname: Møller-Larsen
authors.forename: V E
authors.initials: VE
authors.lastname: Knudsen
authors.forename: B W
authors.initials: BW
authors.lastname: Nielsen
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D004087:Dihydroergotamine; D006493:Heparin
vernacular_title: Cirkulatorisk insufficiens under tromboseprofylaktisk behandling med heparin/dihydroergotamin. Virkning eller bivirkning?